Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
ShaoPuAiSi: Received an inquiry letter from the Shanghai Stock Exchange regarding the proposed acquisition of 100% equity of Shanghai Qinli for 528 million yuan.
Recently, Saplus announced that it plans to acquire 100% equity of Shanghai Qinli held by Yihe Medical and Yanghe Industrial for 528 million yuan in cash. After the completion of this acquisition, Saplus will directly hold all shares of Shanghai Qinli and indirectly own 100% of Shanghai Tianlun Hospital.
This transaction constitutes a related-party transaction, with the counterparties being the company’s controlling shareholder Yanghe Industrial and its concerted party Yihe Medical. Prior to the transaction, the company did not hold any equity in Shanghai Qinli. After the acquisition, it will directly hold 100% of its shares and indirectly own 100% of its wholly owned subsidiary, Tianlun Hospital. The deal includes performance commitment clauses, with the target company promising net profits of no less than 32.4 million yuan, 37.3 million yuan, and 42.65 million yuan for 2026 to 2028, respectively, totaling a net profit of at least 112 million yuan.
On the same day, Saplus disclosed that it received an inquiry letter from the Shanghai Stock Exchange regarding this matter. The inquiry letter requests Saplus to disclose the reasonableness and fairness of the transaction valuation, the achievability of the performance commitments, the sources of funds and payment ability, the ownership, operational qualifications of the target assets, and transitional arrangements. Saplus is required to respond in writing within five trading days to these questions.
(Saplus Announcement)
(Edited by: Yang Yan, Lin Chen)
Keywords: Healthcare